Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067626 · ClinicalTrials.gov registry record · Phase 2
Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes
A Phase 2 study, sponsored by Griffin Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00067626 is a Phase 2 study that has completed, run by Griffin Hospital. The registered enrollment target is 60 participants.
The verdict
NCT00067626, a Phase 2 study, has completed, sponsored by Griffin Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of Chromium on glucose tolerance and endothelial function in people at risk for type II diabetes.
Interventions
- DIETARY_SUPPLEMENT Chromium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067626
The ClinicalTrials.gov registry entry for NCT00067626 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Griffin Hospital, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chromium is the first listed.
NCT00067626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067626 about?
NCT00067626 is a clinical study titled "Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes". The purpose of this study is to investigate the effects of Chromium on glucose tolerance and endothelial function in people at risk for type II diabetes.
What is the current status of trial NCT00067626?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2005-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00067626?
The interventions under investigation include: Chromium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00067626?
This trial is sponsored by Griffin Hospital, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.